ACRS · Aclaris Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Aclaris Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company. It Focuses On Developing Novel Drug Candidates For Immuno-Inflammatory Diseases Using Its Proprietary Kinect Drug Discovery Platform. The Company'S Pipeline Consists Of The Following Key Product Candidates: Bosakitug (Ati-045), An Investigational, Novel, Humanized Anti-Tslp Monoclonal Antibody Being Developed For Patients With Severe Asthma, Copd, And Chronic Rhinosinusitis With Nasal Polyps; Ati-2138, Being Developed For The Potential Treatment Of T Cell-Mediated Autoimmune Diseases; And Ati-052 And Ati-9494. Additionally, It Has An Investigational Product Candidate, Lepzacitinib (Ati-1777), Which Is Being Focused Upon As A Potential Treatment For Atopic Dermatitis And Potentially Other Dermatologic Conditions.

HealthcareNasdaqUS

FLOAT

121.5M

FREE FLOAT %

87%

SHARES O/S

139.8M

MARKET CAP

$552.0M

EXCHANGE

Nasdaq

COUNTRY

ACRS Catalyst History

No catalysts recorded for ACRS yet

Day Trader Sniper hasn't classified a publishable catalyst for ACRS yet. New events appear here as they're scored.

Be early on the next ACRS spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

ACRS · Aclaris Therapeutics, Inc.

ACRS Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.